Kompensatorische Hypertrophie der Leber nach externer Strahlentherapie bei primärem Leberkrebs

Translated title of the contribution: Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer

Chai Hong Rim, Sangjoon Park, Joong Yeol Woo, Jinsil Seong

Research output: Contribution to journalArticle

Abstract

Purpose: We investigated whether external beam radiotherapy (EBRT) could induce compensatory liver hypertrophy in liver cancers and assessed related clinical factors. Methods: A total of 82 consecutive patients receiving EBRT for hepatocellular carcinoma (n = 77) or cholangiocarcinoma (n = 5) from April 2012 to June 2014 were recruited and divided into two subgroups according to tumor location in the right or left lobe. The left lateral and right lobes were considered as unirradiated volumes accordingly. Total liver volume (TLV), nontumor liver volume (NLV), left and right lobe whole volume (LLWV and RLWV, respectively), volume of liver irradiated < 30 Gy (V < 30Gy ), Child–Pugh (CPS) score, future liver remnant (FLR) ratio, and percentage of FLR hypertrophy from baseline (%FLR) were assessed. Results: In the right lobe group, %FLR hypertrophy and LLWV increased significantly at all follow-ups (p < 0.001). %FLR hypertrophy steadily increased until the fourth follow-up. Multivariate analysis showed that the factor associated with maximum %FLR hypertrophy was tumor extent (upper or lower lobe vs. both lobes; p = 0.022). Post-RT treatments including transarterial chemoembolization or hepatic arterial infusion chemotherapy were associated with a CPS increase ≥ 2 (p = 0.002). Analysis of the RT only subgroup also showed a significant increase of %FLR until the fourth follow-up (p < 0.001). In the left lobe group, %FLR hypertrophy and RLWV showed no significant changes during follow-up. Conclusion: Significant compensatory hypertrophy of the liver was observed, with a steady increase of %FLR hypertrophy until the fourth follow-up (median: 396 days). Locally advanced tumors extending across the upper and lower right lobe were a significant factor for compensating hypertrophy after EBRT.

Original languageGerman
Pages (from-to)1017-1029
Number of pages13
JournalStrahlentherapie und Onkologie
Volume194
Issue number11
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Liver Neoplasms
Hypertrophy
Radiotherapy
Liver
Neoplasms
Cholangiocarcinoma
Hepatocellular Carcinoma
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging
  • Oncology

Cite this

Rim, Chai Hong ; Park, Sangjoon ; Woo, Joong Yeol ; Seong, Jinsil. / Kompensatorische Hypertrophie der Leber nach externer Strahlentherapie bei primärem Leberkrebs. In: Strahlentherapie und Onkologie. 2018 ; Vol. 194, No. 11. pp. 1017-1029.
@article{47d21a1ef8d0443989664bc3b7ef2239,
title = "Kompensatorische Hypertrophie der Leber nach externer Strahlentherapie bei prim{\"a}rem Leberkrebs",
abstract = "Purpose: We investigated whether external beam radiotherapy (EBRT) could induce compensatory liver hypertrophy in liver cancers and assessed related clinical factors. Methods: A total of 82 consecutive patients receiving EBRT for hepatocellular carcinoma (n = 77) or cholangiocarcinoma (n = 5) from April 2012 to June 2014 were recruited and divided into two subgroups according to tumor location in the right or left lobe. The left lateral and right lobes were considered as unirradiated volumes accordingly. Total liver volume (TLV), nontumor liver volume (NLV), left and right lobe whole volume (LLWV and RLWV, respectively), volume of liver irradiated < 30 Gy (V < 30   Gy ), Child–Pugh (CPS) score, future liver remnant (FLR) ratio, and percentage of FLR hypertrophy from baseline ({\%}FLR) were assessed. Results: In the right lobe group, {\%}FLR hypertrophy and LLWV increased significantly at all follow-ups (p < 0.001). {\%}FLR hypertrophy steadily increased until the fourth follow-up. Multivariate analysis showed that the factor associated with maximum {\%}FLR hypertrophy was tumor extent (upper or lower lobe vs. both lobes; p = 0.022). Post-RT treatments including transarterial chemoembolization or hepatic arterial infusion chemotherapy were associated with a CPS increase ≥ 2 (p = 0.002). Analysis of the RT only subgroup also showed a significant increase of {\%}FLR until the fourth follow-up (p < 0.001). In the left lobe group, {\%}FLR hypertrophy and RLWV showed no significant changes during follow-up. Conclusion: Significant compensatory hypertrophy of the liver was observed, with a steady increase of {\%}FLR hypertrophy until the fourth follow-up (median: 396 days). Locally advanced tumors extending across the upper and lower right lobe were a significant factor for compensating hypertrophy after EBRT.",
author = "Rim, {Chai Hong} and Sangjoon Park and Woo, {Joong Yeol} and Jinsil Seong",
year = "2018",
month = "11",
day = "1",
doi = "10.1007/s00066-018-1342-y",
language = "German",
volume = "194",
pages = "1017--1029",
journal = "Strahlentherapie und Onkologie",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "11",

}

Kompensatorische Hypertrophie der Leber nach externer Strahlentherapie bei primärem Leberkrebs. / Rim, Chai Hong; Park, Sangjoon; Woo, Joong Yeol; Seong, Jinsil.

In: Strahlentherapie und Onkologie, Vol. 194, No. 11, 01.11.2018, p. 1017-1029.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Kompensatorische Hypertrophie der Leber nach externer Strahlentherapie bei primärem Leberkrebs

AU - Rim, Chai Hong

AU - Park, Sangjoon

AU - Woo, Joong Yeol

AU - Seong, Jinsil

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Purpose: We investigated whether external beam radiotherapy (EBRT) could induce compensatory liver hypertrophy in liver cancers and assessed related clinical factors. Methods: A total of 82 consecutive patients receiving EBRT for hepatocellular carcinoma (n = 77) or cholangiocarcinoma (n = 5) from April 2012 to June 2014 were recruited and divided into two subgroups according to tumor location in the right or left lobe. The left lateral and right lobes were considered as unirradiated volumes accordingly. Total liver volume (TLV), nontumor liver volume (NLV), left and right lobe whole volume (LLWV and RLWV, respectively), volume of liver irradiated < 30 Gy (V < 30   Gy ), Child–Pugh (CPS) score, future liver remnant (FLR) ratio, and percentage of FLR hypertrophy from baseline (%FLR) were assessed. Results: In the right lobe group, %FLR hypertrophy and LLWV increased significantly at all follow-ups (p < 0.001). %FLR hypertrophy steadily increased until the fourth follow-up. Multivariate analysis showed that the factor associated with maximum %FLR hypertrophy was tumor extent (upper or lower lobe vs. both lobes; p = 0.022). Post-RT treatments including transarterial chemoembolization or hepatic arterial infusion chemotherapy were associated with a CPS increase ≥ 2 (p = 0.002). Analysis of the RT only subgroup also showed a significant increase of %FLR until the fourth follow-up (p < 0.001). In the left lobe group, %FLR hypertrophy and RLWV showed no significant changes during follow-up. Conclusion: Significant compensatory hypertrophy of the liver was observed, with a steady increase of %FLR hypertrophy until the fourth follow-up (median: 396 days). Locally advanced tumors extending across the upper and lower right lobe were a significant factor for compensating hypertrophy after EBRT.

AB - Purpose: We investigated whether external beam radiotherapy (EBRT) could induce compensatory liver hypertrophy in liver cancers and assessed related clinical factors. Methods: A total of 82 consecutive patients receiving EBRT for hepatocellular carcinoma (n = 77) or cholangiocarcinoma (n = 5) from April 2012 to June 2014 were recruited and divided into two subgroups according to tumor location in the right or left lobe. The left lateral and right lobes were considered as unirradiated volumes accordingly. Total liver volume (TLV), nontumor liver volume (NLV), left and right lobe whole volume (LLWV and RLWV, respectively), volume of liver irradiated < 30 Gy (V < 30   Gy ), Child–Pugh (CPS) score, future liver remnant (FLR) ratio, and percentage of FLR hypertrophy from baseline (%FLR) were assessed. Results: In the right lobe group, %FLR hypertrophy and LLWV increased significantly at all follow-ups (p < 0.001). %FLR hypertrophy steadily increased until the fourth follow-up. Multivariate analysis showed that the factor associated with maximum %FLR hypertrophy was tumor extent (upper or lower lobe vs. both lobes; p = 0.022). Post-RT treatments including transarterial chemoembolization or hepatic arterial infusion chemotherapy were associated with a CPS increase ≥ 2 (p = 0.002). Analysis of the RT only subgroup also showed a significant increase of %FLR until the fourth follow-up (p < 0.001). In the left lobe group, %FLR hypertrophy and RLWV showed no significant changes during follow-up. Conclusion: Significant compensatory hypertrophy of the liver was observed, with a steady increase of %FLR hypertrophy until the fourth follow-up (median: 396 days). Locally advanced tumors extending across the upper and lower right lobe were a significant factor for compensating hypertrophy after EBRT.

UR - http://www.scopus.com/inward/record.url?scp=85051420107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051420107&partnerID=8YFLogxK

U2 - 10.1007/s00066-018-1342-y

DO - 10.1007/s00066-018-1342-y

M3 - Article

C2 - 30105451

AN - SCOPUS:85051420107

VL - 194

SP - 1017

EP - 1029

JO - Strahlentherapie und Onkologie

JF - Strahlentherapie und Onkologie

SN - 0179-7158

IS - 11

ER -